Treatment of non-melanoma skin cancer: immunotherapy as a viable option.
Shumack
Stephen
S
Department of Dermatology, St George Hospital, University of NSW, Sydney, St. George Dermatology, Level 3, 22 Belgrave Street, Kogarah, NSW 2217, Sydney, Australia. sshumack@bigpond.com
Rigel
Darrell
D
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000634:Aminoquinolines / Q000627:therapeutic use*; D002280:Basal Cell Carcinoma / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D006801:Humans; D000077271:Imiquimod; D007642:Keratosis / Q000188:drug therapy* / Q000209:etiology; D012878:Skin Neoplasms / Q000188:drug therapy*; D016896:Treatment Outcome; D014466:Ultraviolet Rays / Q000009:adverse effects
D000276:Adjuvants, Immunologic; D000634:Aminoquinolines; D000077271:Imiquimod